Coherus Oncology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. 

CEO
Denny M. Lanfear
CEODenny M. Lanfear
Employees
147
Employees147
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2010
Founded2010
Employees
147
Employees147

CHRS Key Statistics

Market cap
80.76M
Market cap80.76M
Price-Earnings ratio
-0.54
Price-Earnings ratio-0.54
Dividend yield
—
Dividend yield—
Average volume
3.07M
Average volume3.07M
High today
$0.54
High today$0.54
Low today
$0.5028
Low today$0.5028
Open price
$0.53
Open price$0.53
Volume
4.31M
Volume4.31M
52 Week high
$2.62
52 Week high$2.62
52 Week low
$0.5028
52 Week low$0.5028

Stock Snapshot

Coherus Oncology(CHRS) stock is priced at $0.53, giving the company a market capitalization of 80.76M. It carries a P/E multiple of -0.54.

On 2026-11-16, Coherus Oncology(CHRS) stock moved within a range of $0.50 to $0.54. With shares now at $0.53, the stock is trading +4.5% above its intraday low and -2.7% below the session's peak.

Trading activity shows a volume of 4.31M, compared to an average daily volume of 3.07M.

The stock's 52-week range extends from a low of $0.50 to a high of $2.62.

The stock's 52-week range extends from a low of $0.50 to a high of $2.62.

CHRS News

TipRanks 5d
Coherus Biosciences Earnings Call: Oncology Growth Meets Cash Pressure

Coherus Biosciences ((CHRS)) has held its Q3 earnings call. Read on for the main highlights of the call. Coherus Biosciences’ earnings call carried a mostly po...

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own CHRS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.